Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043546 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Melisa B Nicoud und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biología Tumoral e Inflamación, Instituto de Investigaciones Biomédicas (BIOMED), Facultad de Ciencias Médicas, Pontificia Universidad…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción Científica y Tecnológica, National Scientific and Technical Research Council, Pontifical Catholic University of Argentina.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Currently, paclitaxel (PTX) represents the first-line therapy for TNBC; however it presents a hydrophobic behavior and produces severe adverse effects. The aim of this work is to improve the therapeutic index of PTX through the design and characterization of novel nanomicellar polymeric formulations composed of a biocompatible copolymer Soluplus® (S), surface-decorated with glucose (GS), and co-loaded either with histamine (HA, 5 mg/mL) and/or PTX (4 mg/mL). Their micellar size, evaluated by dynamic light scattering, showed a hydrodynamic diameter between 70 and 90 nm for loaded nanoformulations with a unimodal size distribution. Cytotoxicity and apoptosis assays were performed to assess their efficacy in vitro in human MDA-MB-231 and murine 4T1 TNBC cells rendering optimal antitumor efficacy in both cell lines for the nanoformulations with both drugs. In a model of TNBC developed in BALB/c mice with 4T1 cells, we found that all loaded micellar systems reduced tumor volume and that both HA and HA-PTX-loaded SG micelles reduced tumor weight and neovascularization compared with the empty micelles. We conclude that HA-PTX co-loaded micelles in addition to HA-loaded formulations present promising potential as nano-drug delivery systems for cancer chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Biología Tumoral e Inflamación, Instituto de Investigaciones Biomédicas (BIOMED), Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina (UCA), Consejo Nacional de Investigaciones Científ…
- Cátedra de Tecnología Farmacéutica I, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina.
- Instituto de Tecnología Farmacéutica y Biofarmacia (InTecFyB), Universidad de Buenos Aires, Buenos Aires 1113, Argentina.
- Laboratorio de Psiconeuroendocrinoinmunología, Instituto de Investigaciones Biomédicas (BIOMED), Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina (UCA), Consejo Nacional de Investigaciones Científ…
- Laboratorio de Radioisótopos, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina.
- Servicio de Patología, Hospital Británico de Buenos Aires, Buenos Aires 1280, Argentina.
ORCID-Profile: Mara R Rubinstein, Vanina A Medina
Förderung
- Agencia Nacional de Promoción Científica y Tecnológica
- National Scientific and Technical Research Council
- Pontifical Catholic University of Argentina
- National Agency for Scientific and Technological Promotion
Zitieren
APA
Nicoud, M. B., Ospital, I. A., Táquez Delgado, M. A., Riedel, J., Fuentes, P., Bernabeu, E., Rubinstein, M. R., Lauretta, P., Martínez Vivot, R., Aguilar, M. L. Á., Salgueiro, M. J., Speisky, D., Moretton, M. A., Chiappetta, D. A., & Medina, V. A. (2023). Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043546
Vancouver
Nicoud MB, Ospital IA, Táquez Delgado MA, Riedel J, Fuentes P, Bernabeu E, et al. Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043546
BibTeX
@article{Nicoud2023,
author = {Nicoud, Melisa B and Ospital, Ignacio A and Táquez Delgado, Mónica A and Riedel, Jennifer and Fuentes, Pedro and Bernabeu, Ezequiel and Rubinstein, Mara R and Lauretta, Paolo and Martínez Vivot, Rocío and Aguilar, María de Los Ángeles and Salgueiro, María J and Speisky, Daniela and Moretton, Marcela A and Chiappetta, Diego A and Medina, Vanina A},
title = {Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043546}
}
EUVIMED